Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary presents mixed indicators. Financial performance shows flat revenue and extended sales cycles, but a significant rise in hyperscaler revenue and increased EBITDA margins. The shareholder return plan is positive with share repurchases. However, uncertainties in the IBM relationship and elongated sales cycles pose risks. The Q&A highlights challenges in revenue growth due to macroeconomic factors and regulatory concerns, with management's responses lacking clarity on resolving these issues. Overall, these factors suggest a neutral stock price movement over the next two weeks.
Free Cash Flow Generated over $400 million in fiscal year 2026, relatively in line with fiscal 2025. This performance was driven by stronger cash collections and lower net CapEx in the fourth quarter.
Revenue $15.1 billion for fiscal year 2026, flat from the prior year on a reported basis and down 3% in constant currency. Revenue was impacted by extended sales cycles, particularly in the U.K. and strategic markets, and the evolution of the relationship with IBM.
Adjusted EBITDA $2.7 billion in fiscal 2026. Adjusted EBITDA margin increased 100 basis points year-over-year, reflective of a mix shift in the business as more post-spin signings flow to the P&L.
Adjusted Pretax Income $581 million in fiscal 2026. Adjusted pretax margin increased 60 basis points year-over-year, driven by a mix shift in the business and post-spin signings.
Hyperscaler-Related Revenue $1.9 billion in fiscal 2026, up 59% versus last year. This growth exceeded the 50% growth expectation at the beginning of the year and reflects strengthened core capabilities and partnerships.
Signings $13.5 billion in fiscal 2026. Signings were impacted by extended sales cycles and changes in customer procurement behavior, particularly in the U.K. and strategic markets.
Net CapEx $543 million in fiscal 2026, up $20 million from last year. Lower than anticipated due to changing customer consumption behaviors where they are buying directly from IBM.
Cash Balance $2.6 billion as of March 31, 2026, up $1.3 billion from December 31, 2025. This includes $300 million from operations and $1 billion drawn under the revolving credit facility.
Debt Maturities Well-laddered from late 2026 to 2041. Annualized run rate of spend with IBM reduced to less than $2 billion by the end of fiscal 2026, down from nearly $4 billion at the time of spin-off.
Share Repurchase Repurchased 11.6 million shares of common stock at a cost of $304 million in fiscal 2026, reducing outstanding shares by 6% since the inception of the program.
Kyndryl Consult: Delivered double-digit revenue growth for the third consecutive year. Investments include hiring engineers, human systems architects, and AI innovation labs. Positioned for another year of strong revenue growth.
Hyperscaler-related revenue: Achieved nearly $2 billion in revenue in fiscal 2026, growing from essentially zero four years ago. Focused on data sovereignty and agentic modernization.
Alliance partnerships: Strengthened collaborations with hyperscalers and private cloud providers like Broadcom, Dell, and HP Enterprise. Positioned for continued growth in fiscal 2027.
New deals and scope: Signed 38 deals exceeding $50 million, with over 30% being new scope or new logos. Signed more than 125 large deals over the last three years.
AI-driven operational efficiencies: Using AI agents to resolve incidents 70%-90% faster, reduce root cause analysis cycles by 75%, and cut dependency on people's time by 50%-70%.
Advanced delivery initiative: Achieved $1 billion in annual savings through automation and AI integration.
Workforce rebalancing: Expected to yield $400-$500 million in annualized savings by fiscal 2028.
Evolving IBM relationship: Revenue impacted by customers procuring directly from IBM, but profitability remains unaffected.
Extended Sales Cycles: The company is experiencing extended sales cycles, particularly in the U.K. and strategic markets, which is impacting revenue and signings performance.
Customer Decision-Making: Customers are becoming more deliberate in their IT decision-making, driven by factors like sovereignty, AI, and cyber preparedness, which could slow down modernization and transformation initiatives.
Evolving Relationship with IBM: Changes in how customers consume IBM innovation are leading to a reduction in the size of signings and revenue over time, creating headwinds for the company.
Economic and Operational Costs: Increasing tech and operational costs are making modernization a necessity rather than an option, but traditional approaches to modernization are labor-intensive, slow, and often fail to deliver expected ROI.
AI and IT Infrastructure Challenges: Many customers struggle to generate meaningful returns on AI due to outdated IT environments, infrastructure, and business processes, which are not built for modern AI applications.
Material Weaknesses in Internal Controls: The company disclosed material weaknesses in internal controls, which could impact financial reporting and operational efficiency.
Workforce Rebalancing Actions: The company is undertaking workforce rebalancing actions, which involve significant charges and could lead to disruptions in the short term, even though they are expected to yield long-term savings.
Dependency on IBM Revenue: A significant portion of revenue is still tied to IBM, and changes in this relationship have already halved the annualized run rate of spend with IBM, impacting revenue streams.
Revenue Growth: Kyndryl expects revenue to be flat to down 2% in constant currency for fiscal 2027. Growth is anticipated in Kyndryl Consult and alliances-related revenue streams, while headwinds are expected from the evolving relationship with IBM.
Profitability: The company targets adjusted pretax income in the range of $600 million to $700 million for fiscal 2027, including $200 million in workforce rebalancing charges. These actions are expected to yield annualized savings of $400 million to $500 million in fiscal 2028.
Free Cash Flow: Free cash flow is projected to be in the range of $400 million to $500 million for fiscal 2027, with stronger cash flow expected in the second half of the year.
Long-Term Financial Targets: Kyndryl aims to achieve more than $1.2 billion in adjusted pretax income and over $1 billion in free cash flow by fiscal 2028, supported by low single-digit constant currency revenue growth.
Kyndryl Consult and Hyperscaler Revenue: Strong growth is expected in Kyndryl Consult and hyperscaler-related revenue streams in fiscal 2027, building on double-digit growth in fiscal 2026.
Operational Efficiency: The company plans to continue embedding AI and automation into operations, with workforce rebalancing actions expected to improve SG&A efficiencies and reduce costs.
Customer Modernization Needs: Kyndryl anticipates increased demand for modernization services, including private cloud and AI-led solutions, as customers face rising tech and operational costs.
Share Repurchase Program: Under the share repurchase authorization, Kyndryl bought back 11.6 million shares of common stock at a cost of $304 million in fiscal 2026, of which 3.3 million shares were purchased in the fourth quarter at a cost of $49 million. Since the inception of the program, the company has repurchased 6% of its outstanding shares. As of March 31, there is approximately $300 million capacity available under the current authorization.
The earnings call summary presents mixed indicators. Financial performance shows flat revenue and extended sales cycles, but a significant rise in hyperscaler revenue and increased EBITDA margins. The shareholder return plan is positive with share repurchases. However, uncertainties in the IBM relationship and elongated sales cycles pose risks. The Q&A highlights challenges in revenue growth due to macroeconomic factors and regulatory concerns, with management's responses lacking clarity on resolving these issues. Overall, these factors suggest a neutral stock price movement over the next two weeks.
The earnings call presented mixed signals. Strong growth in hyperscaler-related revenue and a robust share repurchase program are positives. However, the Q&A revealed concerns about extended sales cycles, market dynamics, and a revision in free cash flow guidance, which offset some positives. The lack of clear guidance due to an ongoing review adds uncertainty. The overall sentiment is neutral, as positive long-term growth drivers are balanced by short-term challenges and uncertainties.
The earnings call reveals strong financial performance, with significant growth in Kyndryl Consult revenues and hyperscaler-related revenues. Adjusted EBITDA and pretax income have increased substantially, indicating operational efficiency. The company is investing in AI and acquisitions, enhancing its competitive position. Shareholder returns through repurchases and optimistic guidance for the second half further support a positive outlook. Despite some uncertainties in management's responses, the overall sentiment is positive, suggesting a likely stock price increase.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.